Brizwell Pharmaceuticals Private Limited
About Brizwell Pharmaceuticals Private Limited
Data last updated:
Brizwell Pharmaceuticals Private Limited is a private limited company based in Secunderabad, Telangana, India. It was incorporated on 03 October 2023.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U46497TS2023PTC177594.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Santhosh Sonti (Managing Director) and Rentala Swetha.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Secunderabad, Telangana.
As per the financials filed for FY 2024, the company reported a revenue of ₹4.29 Lakh. For the same year it recorded a net profit of ₹6,151 (net margin 1.4%) and EBITDA of ₹26,256 (EBITDA margin 6.1%).
Company details
Contact details
Brizwell Pharmaceuticals Private Limited's registered office is in Secunderabad, Telangana.
- Registered AddressH.No. 3 – 5 – 15, Road.No.1 Krishna Nagar, Secunderabad, Telangana, India – 500040
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Brizwell Pharmaceuticals Private Limited
FY 2025 filings availableBrizwell Pharmaceuticals Private Limited reported revenue of ₹4.29 Lakh for FY 2024.
Financial Statement Summary
| Metrics | FY 2023-24 |
|---|---|
| Profit and Loss Statement | |
| Revenue from Operations | |
| Other Income | |
| Total Revenue | |
| Cost of Materials Consumed | |
| Employee Benefit Expense | |
| Finance Costs | |
| Depreciation and Amortisation | |
| Other Expenses | |
| Total Expenses | |
| EBITDA | ₹26,256 |
| Profit Before Tax | |
| Tax Expense | |
| Net Profit (PAT) | ₹6,151 |
| Balance Sheet | |
| Share Capital | |
| Reserves and Surplus | |
| Net Worth (Total Equity) | |
| Long-term Borrowings | |
| Short-term Borrowings | |
| Trade Payables | |
| Total Liabilities | |
| Fixed Assets | |
| Investments | |
| Inventories | |
| Trade Receivables | |
| Cash and Bank Balance | |
| Total Assets | |
Financial Ratios
| Metrics | FY 2023-24 |
|---|---|
| Profitability | |
| EBITDA Margin | 6.1% |
| Net Profit Margin | 1.4% |
| Return on Equity (ROE) | |
| Return on Capital Employed (ROCE) | |
| Return on Assets (ROA) | |
| Liquidity and Debt | |
| Current Ratio | |
| Quick Ratio | |
| Debt-to-Equity Ratio | |
| Interest Coverage Ratio | |
| Efficiency and Growth | |
| Asset Turnover | |
| Receivable Days | |
| Payable Days | |
| Inventory Days | |
| Revenue Growth | |
| Net Profit Growth | |
To see the full financial statements and ratios of Brizwell Pharmaceuticals Private Limited, buy the company report.
Board of directors of Brizwell Pharmaceuticals Private Limited
Brizwell Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rentala Swetha | Director | 03 Oct 2023 | 3 Years 0 Months | Current |
| Santhosh Sonti | Managing Director | 03 Oct 2023 | 3 Years 0 Months | Current |
Peer comparison
Brizwell Pharmaceuticals Private Limited is compared with the 10 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Byblis Pharmaceuticals Private Limited | ₹4.31 Lakh (FY 2024) | 19.0% | New Delhi, Delhi, India | |||
| Midstar Pharmaceuticals Private Limited | ₹4.3 Lakh (FY 2025) | -59.0% | Thane, Maharashtra, India | |||
| Celestis Pharmaceuticals Private Limited | ₹4.3 Lakh (FY 2024) | -31.0% | Ahmedabad, Gujarat, India | |||
| Swansaw Pharmaceuticals Private Limited | ₹4.29 Lakh (FY 2024) | Visakhapatnam, Andhra Pradesh, India | ||||
| Guyer Pharmaceuticals Private Limited | ₹4.29 Lakh (FY 2019) | -9.0% | Daltonganj, Jharkhand, India | |||
| Brizwell Pharmaceuticals Private Limitedthis company | ₹4.29 Lakh (FY 2024) | ₹6,151 | 1.4% | Secunderabad, Telangana, India | ||
| True Pill Pharmaceuticals Private Limited | ₹4.28 Lakh (FY 2024) | 132.0% | Bulandshahar, Uttar Pradesh, India | |||
| Medwock Pharmaceuticals Private Limited | ₹4.28 Lakh (FY 2020) | New Delhi, Delhi, India | ||||
| Prophends Pharmaceuticals (OPC) Private Limited | ₹4.26 Lakh (FY 2025) | 55.0% | Patna, Bihar, India | |||
| Glorywarrior Pharmaceuticals (OPC) Private Limited | ₹4.26 Lakh (FY 2022) | Ratnagiri, Maharashtra, India | ||||
| Aptaas Pharmaceuticals Private Limited | ₹4.25 Lakh (FY 2018) | -6.0% | New Delhi, Delhi, India |
To see the full peer comparison of Brizwell Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Brizwell Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Brizwell Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Brizwell Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Brizwell Pharmaceuticals Private Limited has 2 board changes on record since 2023: 2 appointments. The latest: Rentala Swetha was appointed as Director on 03 Oct 2023.
Frequently asked questions
Brizwell Pharmaceuticals is an active private limited company based in Secunderabad, Telangana, India. It was incorporated on 03 October 2023 (3+ years old) and is registered under CIN U46497TS2023PTC177594.
Brizwell Pharmaceuticals has 2 current directors:
- Santhosh Sonti - Managing Director
- Rentala Swetha - Director
The latest financial statements of Brizwell Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2024 are in the company report.
The CIN (Corporate Identification Number) of Brizwell Pharmaceuticals is U46497TS2023PTC177594. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Brizwell Pharmaceuticals was incorporated on 03 October 2023, making it 3+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of Brizwell Pharmaceuticals by revenue are Byblis Pharmaceuticals Private Limited, Midstar Pharmaceuticals Private Limited, Celestis Pharmaceuticals Private Limited, Swansaw Pharmaceuticals Private Limited, Guyer Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Pharmaceuticals).
Rentala Swetha was appointed as Director on 03 Oct 2023. Santhosh Sonti was appointed as Managing Director on 03 Oct 2023.
The registered office of Brizwell Pharmaceuticals is at H.No. 3 – 5 – 15, Road.No.1 Krishna Nagar, Secunderabad, Telangana, India – 500040.
Brizwell Pharmaceuticals can be reached at its registered office: H.No. 3 – 5 – 15, Road.No.1 Krishna Nagar, Secunderabad, Telangana, India – 500040.
Brizwell Pharmaceuticals is registered under the jurisdiction of the Registrar of Companies (ROC), Hyderabad.